Focus: Membrane Solutions is a Shanghai-based biotechnology company founded in 2024, specializing in lab filtration products for research and diagnostic applications. With 1-50 employees and a recently public status, it operates as a niche player in the filtration technology segment.
Profile data last refreshed 32m ago · AI intelligence enriched 1w ago
Growing — net +5 jobs in 30d
5 jobs added vs 0 removed. Steady team buildout.
Membrane Solutions is a highly speculative early-stage opportunity best suited for risk-tolerant professionals seeking equity upside and foundational roles in a nascent company, not career stability.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Membrane Solutions
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Membrane Solutions's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles